Pacligen (Paclitaxel)

Paclitaxel, the active ingredient in Pacligen, is a chemotherapy agent presented as a sterile powder for intravenous infusion use. It treats various solid tumours and is administered to adult oncology patients. GNH USA supplies Pacligen as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

GNH USA supplies Pacligen as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

Pacligen is a taxane‑derived disease‑modifying treatment that offers benefits in several oncologic pathways and tumor types.

- Breast cancer: Improves the overall response rate when combined with anthracycline‑based regimens. - Ovarian cancer: Enhances the efficacy of platinum‑based chemotherapy in first‑line treatment of patients with advanced disease. - Non‑small cell NSCLC ( non‑small cell lung cancer ): Provides benef‑a benef by the   g  g  t  g  g \